Cost-effectiveness analysis of fosnetupitant in patients receiving cisplatin in Japan: analysis based on real-world data.

MLA

Inano, Hiroshi, et al. “Cost-Effectiveness Analysis of Fosnetupitant in Patients Receiving Cisplatin in Japan: Analysis Based on Real-World Data.” Supportive Care in Cancer, vol. 33, no. 2, Feb. 2025, pp. 1–9. EBSCOhost, https://doi.org/10.1007/s00520-025-09210-5.

APA

Inano, H., Morimoto, Y., Kitagawa, K., Shibuya, A., Nakagomi, K., Ota, T., Anzo, Y., Miyauchi, R., Shono, A., Watanabe, K., & Otori, K. (2025). Cost-effectiveness analysis of fosnetupitant in patients receiving cisplatin in Japan: analysis based on real-world data. Supportive Care in Cancer, 33(2), 1–9. https://doi.org/10.1007/s00520-025-09210-5

Chicago

Inano, Hiroshi, Yoshihito Morimoto, Kanata Kitagawa, Akito Shibuya, Kozue Nakagomi, Tomohiro Ota, Yuri Anzo, et al. 2025. “Cost-Effectiveness Analysis of Fosnetupitant in Patients Receiving Cisplatin in Japan: Analysis Based on Real-World Data.” Supportive Care in Cancer 33 (2): 1–9. doi:10.1007/s00520-025-09210-5.